Mitotic recombination and compound-heterozygous mutations are predominant NF1-inactivating mechanisms in children with juvenile myelomonocytic leukemia and neurofibromatosis type 1. (Q33632274)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Mitotic recombination and compound-heterozygous mutations are predominant NF1-inactivating mechanisms in children with juvenile myelomonocytic leukemia and neurofibromatosis type 1. |
scientific article |
Statements
1 reference
Mitotic recombination and compound-heterozygous mutations are predominant NF1-inactivating mechanisms in children with juvenile myelomonocytic leukemia and neurofibromatosis type 1. (English)
1 reference
Jan Stary
1 reference
Doris Steinemann
1 reference
Larissa Arning
1 reference
Inka Praulich
1 reference
Manfred Stuhrmann
1 reference
Charlotte M Niemeyer
1 reference
Christian Flotho
1 reference
16 December 2009
1 reference
1 reference
Identifiers
1 reference